Folletro 2.5 Tablet is used to treat breast cancer in women who have gone through menopause (cessation of menses periods). Breast cancer is a type of cancer that develops in breast cells stimulated by the female sex hormone known as estrogen.

Folletro 2.5 Tablet contains 'Letrozole' that works by blocking the aromatase enzyme, which is involved in the production of the estrogen hormone. 

In some cases, Folletro 2.5 Tablet may cause common side effects such as hypercholesterolemia (increased cholesterol levels), tiredness, weakness, increased sweating, feeling unwell, pain in joints, and hot flushes (feeling of warmth). Do not be reluctant to talk with your doctor if you experience any of these side-effects persistently.

You are advised to take Folletro 2.5 Tablet for as long as your doctor has prescribed it for you, depending on your medical condition. It can be taken with or without food with a glass of water. Do not chew, bite or crush the medicine.

Avoid taking Folletro 2.5 Tablet if you are allergic to it, or if you are pregnant or breastfeeding. Folletro 2.5 Tablet may cause drowsiness and dizziness, so drive only if you are alert. Folletro 2.5 Tablet should not be given to children as safety has not been established. Avoid consuming alcohol along with Folletro 2.5 Tablet as it could lead to increased drowsiness and dizziness. Inform your doctor about your health condition and medications to rule out any side-effects.

Folletro 2.5 Tablet is used in the treatment of Breast cancer. The detailed uses of Folletro 2.5 Tablet are as follows:

• Breast Cancer Treatment: Folletro 2.5 Tablet is primarily prescribed for postmenopausal women with hormone-receptor-positive breast cancer. It works by lowering estrogen levels, which helps slow or halt the growth of certain breast tumours.
• Adjuvant Therapy: After surgery for early-stage breast cancer, Folletro 2.5 Tablet may be used as adjuvant therapy to reduce the risk of recurrence and improve survival rates.
• Neoadjuvant Therapy: Folletro 2.5 Tablet can serve as a neoadjuvant treatment to shrink breast tumours before surgery, facilitating their removal.
• Ovarian Function Suppression: Folletro 2.5 Tablet is occasionally used off-label during fertility treatments to suppress ovarian function, particularly in cases of polycystic ovary syndrome (PCOS).

• Take Folletro 2.5 Tablet with or without food as advised by your doctor.
• It is advised to take Folletro 2.5 Tablet once daily; however, follow your doctor’s recommendation regarding the dosage and duration.
• Swallow Folletro 2.5 Tablet as a whole with a glass of water.
• Do not crush, chew or break it.

• Folletro 2.5 Tablet belongs to the group of anti-cancer medicines called aromatase inhibitors.
• Folletro 2.5 Tablet is used to treat breast cancer in women who have gone through menopause (cessation of periods).
• Folletro 2.5 Tablet helps in slowing down or stopping the growth and/or spreading the tumours to other body parts.

• Do not take Folletro 2.5 Tablet if you are allergic to any of its contents, if you have not yet gone through menopause (still get your periods).
• Talk to your doctor before taking Folletro 2.5 Tablet if you have osteoporosis (thinning of bones), bone fractures, severe liver or kidney disease.
• Folletro 2.5 Tablet may cause inflammation in tendons or tendon injury; contact your doctor if you observe any sign of tendon pain or swelling while taking Folletro 2.5 Tablet.
• Avoid taking Folletro 2.5 Tablet if you are pregnant or breastfeeding.
• Folletro 2.5 Tablet may cause drowsiness and dizziness, so drive only if you are alert.
• Folletro 2.5 Tablet is not recommended for use in children as safety has not been established.
• Avoid consuming alcohol along with Folletro 2.5 Tablet as it could lead to increased drowsiness and dizziness.